Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 81.8M | 92.6M | 81.3M | 80.8M |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 16.6M | 15.9M | 14.5M | 17.0M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 30.5M | 35.5M | 38.9M | 42.3M |
| Tax provision | 8.0M | 6.6M | 10.3M | 12.6M |
| Net income | 22.5M | 28.9M | 28.7M | 29.8M |
| Basic EPS | 2.5 | 2.5 | 3.3 | 3.4 |
| Diluted EPS | 2.5 | 2.5 | 3.3 | 3.4 |
| Basic average shares | 4.0M | 4.0M | 4.0M | 4.0M |
| Diluted average shares | 4.0M | 4.0M | 4.0M | 4.0M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |